The synthetic method for 1-(phenyl)alkyl-3-acyl-1,2,8-triazaspiro[4.5]decanes
DOI:
https://doi.org/10.24959/ophcj.16.874Keywords:
arylhydrazone, reductive alkylation, 1, 4-dihydropyridine, 5-dihydro-4H-pyrazol-4-on, 2, 8-triaza- spiro[4.5]decaneAbstract
Piperidines spiro-fused to other heterocycles and being structural elements of pharmacologically active molecules can be considered as “preferred fragments” of metabotropic receptor ligands. The method for obtaining 1,2,8-triazaspiro [4.5]decane comprising spiroannelation of 1,4-dihydropyridine and pyrazolone cycles. When heating of 1-(phenyl)alkyl-4-[2-[2-arylhyqrazono]-1,3-dioxobutyl]pyridinium halide in pyridine or by reacting of 1-(phenyl)alkyl-4-[2-[2-arylhyqrazono]-1,3-dioxobutyl]pyridinium halides and 1-(phenyl)alkyl-4-{1,3-dioxo-3-phenyl-2-[2-(4-methylphenyl)hydrazono]propyl}pyridinium halides with diisopropylethylamine at 25°C the intramolecular reductive alkylation of the electrophilic pyridinium cation occurs forming 1-(phenyl)alkyl-3-acyl-1,2,8-triazaspiro[4.5]decanes, which are solid coloured substances. The spectral properties of the cyclization products have been studied; formation of the spiro-fused system and the presence of the 1,4-dihydropyridine fragment have been determined. Confi rmation of their structure has been obtained by carrying out the X-ray diffraction of 3-acetyl-8-benzyl-1-phenyl-1,2,8-triazaspiro[4.5]deca-2,6,9-trien-4-one crystal, which, in its turn, has clearly confi rmed orthogonality of the spiro-fused planes. The dihydropyridine ring in the molecule is not fl at and is located in the half-chair conformation with deviation of carbon spiro atom from the plane of the rest atoms of the cycle. This is due to formation of the intramolecular C-H...π hydrogen bond.Downloads
References
- Krafft A. A., Kurt A. A., Thomas A. W., Zimmerli D. Synthesis, 2005, Vol. 19, pp.3245-3252.
- Patchett A. A., Nargund R. P., Tata J. R., Chen M. H., Barakat K. J., Johnston D. B., Cheng K., Chan W. W., Butler B., Hickey G. Proceedings of the National Academy of Sciences of the United States of America, 1995, Vol. 92, No.15, pp.7001-7005.
- Kisel V. M., Kostyrko E. O., Kovtunenko V. A. Chemistry of Heterocyclic Compounds, 2002, Vol. 38, No.8, pp.940-946.
- Bondensgaard K., Ankersen M., Thogersen H. L., Hansen B. S., Wulff B. S., Bywater R.P. Journal of Medicinal Chemistry, 2004, Vol. 47, No.4, pp.888-899.
- Patchett A. A. Journal of Medicinal Chemistry, 2002, Vol. 45, No.26, pp.5609-5616.
- Tsukamoto S., Nagaoka H., Igarashi S., Wanibuchi F., Hidaka K., Tamura T. Chemical and Pharmaceutical Bulletin, 1995, Vol. 43, No.9, pp.1523-1529.
- Smith P. W., Anthony A. W. J., Bell R., Beresford I. J. M., Gore P. M., McElroy A. B., Pritchard J. M., Saez V., Taylor N. R. Journal of Medicinal Chemistry, 1995, Vol. 38, No.19, pp.3772-3779.
- Ahlbrecht H., Krohnke F. Liebigs Annalen der Chemie, 1967, Vol. 704, pp.133-139.
- Sainsbury M., Uttley N. L. Journal of Chemical Society, Perkin Transactions I, 1977, pp.2109-2115.
- Naito N., Miyata O., Ninomiya I. Journal of Chemical Society, Chemical Communications, 1979, pp.517-518.
- Weller D. D., Weller D. L. Tetrahedron Letters, 1982, Vol. 23, No.50, pp.5239-5242.
- Naito N., Ninomiya I. Heterocycles, 1981, Vol. 15, No.2, pp.735-738.
- Kucherenko T. T., Gutsul R. M., Kysel V. M., Kovtunenko V. O. Tetrahedron, 2004, Vol. 60, No.1, pp.211-217.
- Kisel V. M., Kovtunenko V. A., Potikha L. M., Turov A. V., Babichev F. S. Ukrainsky khimichesky zhurnal – Ukrainian chemistry journal, 1993, Vol. 59, No.10, pp.1070-1071.
- Kovtunenko V. A., Potikha L. M., Mishchuk A. A., Turov A. V. Chemistry of Heterocyclic Compounds, 2008, Vol. 44, No.8, pp.1019-1021.
- Kovtunenko V. A., Potikha L. M., Bulda T. S., Zubatyuk R. I., Shishkin O. V. Zhurnal organichnoi ta farmatsevtichnoi khimii – Journal of organic and pharmaceutical chemistry, 2014, Vol. 12, No.2(46), pp.4-14.
- Freeman J. P., Hoare M. J. The Journal of Organic Chemistry, 1971, Vol. 36, No.1, pp.19-23.
- Baldwin J. E., Lever O. W. Jr., Tzodikov N. R. The Journal of Organic Chemistry, 1976, Vol. 41, No.17, pp.2874-2877.
- Winkler F. K., Dunitz J. D. Journal of Molecular Biology, 1971, Vol. 59, No.1, pp.169-182.
- Sheldrick G. M. Acta Crystallographica Section A, 2008, Vol. 64, No.1, pp.112-122.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).